Cargando…
Effects of febuxostat on markers of endothelial dysfunction and renal progression in patients with chronic kidney disease
Hyperuricemia relates to chronic kidney disease (CKD) progression and impaired endothelial function. Febuxostat is potent and effective for decreasing serum uric acid levels. Information for the effect of febuxostat treatment on markers of endothelial dysfunction and renal injury among patients with...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439119/ https://www.ncbi.nlm.nih.gov/pubmed/37596359 http://dx.doi.org/10.1038/s41598-023-40767-5 |